Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 08:35 am Sale |
2024-12-31 | 13G | PTC Therapeutics, Inc. PTCT |
Camber Capital Management LP | 3,200,000 4.150% |
-800,000 (-20.00%) |
Filing History |
| 2025-02-14 08:34 am Sale |
2024-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
Camber Capital Management LP | 0 0.000% |
-2,805,000 (Position Closed) |
Filing History |
| 2025-02-14 08:33 am Sale |
2024-12-31 | 13G | Brookdale Senior Living Inc. BKD |
Camber Capital Management LP | 17,168,525 8.480% |
-1,565,000 (-8.35%) |
Filing History |
| 2025-02-14 08:32 am Sale |
2024-12-31 | 13G | ZimVie Inc. ZIMV |
Camber Capital Management LP | 2,725,000 9.870% |
-525,000 (-16.15%) |
Filing History |
| 2025-02-14 08:32 am Sale |
2024-12-31 | 13G | Myriad Genetics, Inc. MYGN |
Camber Capital Management LP | 3,100,000 3.410% |
-4,535,000 (-59.40%) |
Filing History |
| 2025-02-14 08:30 am Sale |
2024-12-31 | 13G | Solid Biosciences Inc. SLDB |
Camber Capital Management LP | 0 0.000% |
-1,418,440 (Position Closed) |
Filing History |
| 2024-02-14 08:25 am Sale |
2023-12-31 | 13G | Quanterix Corporation QTRX |
Camber Capital Management LP | 0 0.000% |
-3,425,000 (Position Closed) |
Filing History |
| 2024-02-14 08:24 am Purchase |
2023-12-31 | 13G | Myriad Genetics, Inc. MYGN |
Camber Capital Management LP | 7,635,000 8.500% |
635,000 (+9.07%) |
Filing History |
| 2024-02-14 08:23 am Purchase |
2023-12-31 | 13G | Inogen, Inc. INGN |
Camber Capital Management LP | 2,000,000 8.580% |
400,000 (+25.00%) |
Filing History |
| 2024-02-14 08:22 am Purchase |
2023-12-31 | 13G | ZimVie Inc. ZIMV |
Camber Capital Management LP | 3,250,000 12.250% |
650,000 (+25.00%) |
Filing History |
| 2024-02-14 08:21 am Purchase |
2023-12-31 | 13G | Brookdale Senior Living Inc. BKD |
Camber Capital Management LP | 18,733,525 9.780% |
733,525 (+4.08%) |
Filing History |
| 2024-02-14 08:19 am Sale |
2023-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
Camber Capital Management LP | 2,805,000 5.900% |
-1,430,000 (-33.77%) |
Filing History |
| 2023-10-30 09:05 am Purchase |
2023-10-19 | 13G | PTC Therapeutics, Inc. PTCT |
Camber Capital Management LP | 4,000,000 5.310% |
4,000,000 (New Position) |
Filing History |
| 2023-07-24 09:50 am Purchase |
2023-07-14 | 13G | Inogen, Inc. INGN |
Camber Capital Management LP | 1,600,000 6.920% |
1,600,000 (New Position) |
Filing History |
| 2023-02-14 08:46 am Purchase |
2022-12-31 | 13G | Myriad Genetics, Inc. MYGN |
Camber Capital Management LP | 7,000,000 8.640% |
2,300,000 (+48.94%) |
Filing History |
| 2023-02-14 08:40 am Purchase |
2022-12-31 | 13G | Quanterix Corporation QTRX |
Camber Capital Management LP | 3,425,000 9.240% |
425,000 (+14.17%) |
Filing History |
| 2023-02-14 08:36 am Purchase |
2022-12-31 | 13G | ZimVie Inc. ZIMV |
Camber Capital Management LP | 2,600,000 9.970% |
600,000 (+30.00%) |
Filing History |
| 2023-02-14 08:33 am Purchase |
2022-12-31 | 13G | Brookdale Senior Living Inc. BKD |
Camber Capital Management LP | 18,000,000 9.640% |
2,000,000 (+12.50%) |
Filing History |
| 2023-02-14 08:30 am Purchase |
2022-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
Camber Capital Management LP | 4,235,000 9.280% |
2,185,000 (+106.59%) |
Filing History |
| 2023-02-02 2:53 pm Unchanged |
2023-02-02 | 13G | OraSure Technologies, Inc. OSUR |
Camber Capital Management LP | 4,250,000 5.850% |
0 (Unchanged) |
Filing History |